Acute Fibrinous and organizing Pneumonia Associated With Immunotherapy (Pembrolizumab)

Arch Bronconeumol. 2022 May;58(5):425-426. doi: 10.1016/j.arbres.2021.11.009. Epub 2021 Dec 8.

[Article in English, Spanish]

Authors

José Luis Pérez Pérez¹, Ignacio Gayá García-Manso², Raquel García Sevila²

Affiliations

¹ Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, España. Electronic address: joseluisperez2195@hotmail.com.
² Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, España.

PMID: 35312504
DOI: 10.1016/j.arbres.2021.11.009

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized
Humans
Immunologic Factors
Immunotherapy / adverse effects
Pneumonia*

Substances

Antibodies, Monoclonal, Humanized
Immunologic Factors
pembrolizumab